{"id":"NCT00600340","sponsor":"Central European Cooperative Oncology Group","briefTitle":"2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab","officialTitle":"A Randomized Phase III 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab for the First-line Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Locally Recurrent or Metastatic Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2014-09","completion":"2014-12","firstPosted":"2008-01-25","resultsPosted":"2019-12-30","lastUpdate":"2019-12-30"},"enrollment":564,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Breast Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Bevacizumab and Paclitaxel","otherNames":[]},{"type":"BIOLOGICAL","name":"Bevacizumab and Capecitabine","otherNames":[]}],"arms":[{"label":"A Bev+Pac","type":"ACTIVE_COMPARATOR"},{"label":"B Bev+Cap","type":"ACTIVE_COMPARATOR"}],"summary":"First-line treatment of patients with locally recurrent or metastatic, HER2-negative breast cancer who have not received prior chemotherapy for locally recurrent or metastatic disease.","primaryOutcome":{"measure":"Overall Survival (PP Population)","timeFrame":"Time from the date of randomization to the date of death or date last known to be alive, assessed up to approximately 6 years","effectByArm":[{"arm":"Bevacizumab Plus Paclitaxel","deltaMin":30.2,"sd":null},{"arm":"Bevacizumab Plus Capecitabine","deltaMin":26.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1983"},{"comp":"OG000 vs OG001","p":"0.0070"},{"comp":"OG000 vs OG001","p":"0.2024"},{"comp":"OG000 vs OG001","p":"0.0612"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":55,"countries":["Austria","Bosnia and Herzegovina","Bulgaria","Croatia","Czechia","Hungary","Israel","Latvia","Poland","Romania","Serbia","Slovakia"]},"refs":{"pmids":["34037241","27501767","25268370","23312888"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":65,"n":284},"commonTop":["Hypertension","Fatigue","Palmar-plantar erythrodysaesthesia syndrome","Epistaxis","Nausea"]}}